Warning Letter Roundup & Recap – Oct. 4, 2016
FDA finds approval and marketing violations at a Texas dermatology device firm; QS and approval violations noted at a New Jersey maker of collagen-based surgical tools. FDA released warning letters to two device companies this week. Plus: check out Medtech Insight's new FDA Warning Letters Data Tracker.
Register for our free email digests: